Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIROGACESTAT for Soft tissue neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 40 adverse event reports in the FDA FAERS database where NIROGACESTAT was used for Soft tissue neoplasm.

Most Reported Side Effects for NIROGACESTAT

Side Effect Reports % Deaths Hosp.
Diarrhoea 220 44.3% 1 13
Nausea 136 27.4% 0 12
Fatigue 110 22.1% 0 6
Headache 62 12.5% 0 4
Product dose omission issue 60 12.1% 0 4
Rash 59 11.9% 0 8
Vomiting 50 10.1% 0 8
Stomatitis 42 8.5% 1 5
Product dose omission in error 34 6.8% 0 2
Cough 33 6.6% 0 3
Pruritus 31 6.2% 0 2
Intentional underdose 30 6.0% 0 4
Alopecia 28 5.6% 0 2
Abdominal discomfort 25 5.0% 0 0
Hot flush 23 4.6% 0 0

Other Indications for NIROGACESTAT

Product used for unknown indication (263) Desmoid tumour (158) Connective tissue neoplasm (39) Plasma cell myeloma (20) Plasma cell myeloma refractory (11)

Other Drugs Used for Soft tissue neoplasm

PEXIDARTINIB (223) PAZOPANIB (85) VIMSELTINIB (64) IMATINIB (24) NIVOLUMAB (20) CABOZANTINIB S-MALATE (17) SORAFENIB (14) SUNITINIB MALATE (14) CABOZANTINIB (12) IFOSFAMIDE (11)

Related Pages

NIROGACESTAT Full Profile All Soft tissue neoplasm Drugs NIROGACESTAT Demographics NIROGACESTAT Timeline